We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

204 hedge funds and large institutions have $1B invested in Immunogen Inc in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $6.78M | Put options by funds: $3.42M

6% more capital invested

Capital invested by funds: $948M → $1B (+$55.2M)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

8% less funds holding

Funds holding: 222 → 204 (-18)

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Holders
204
Holders Change
-18
Holders Change %
-8.11%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
69
Reduced
68
Closed
44
Calls
$6.78M
Puts
$3.42M
Net Calls
+$3.35M
Net Calls Change
-$1.16M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$27.3M
2
MC
Maverick Capital
Texas
+$18M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.5M
4
Jennison Associates
Jennison Associates
New York
+$16M
5
State Street
State Street
Massachusetts
+$15.8M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$40M
2
ClearBridge Investments
ClearBridge Investments
New York
-$23.1M
3
Renaissance Technologies
Renaissance Technologies
New York
-$8.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$7.67M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$6.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$7.75M +$198K +36,478 +2%
RPAM
27
Rhenman & Partners Asset Management
Sweden
$7.44M +$2.17M +400,000 +36%
QF
28
QVT Financial
New York
$6.82M – – –
Rafferty Asset Management
29
Rafferty Asset Management
New York
$6.79M +$2.28M +420,762 +44%
PA
30
Pinnacle Associates
New York
$6.61M -$83.5K -15,405 -1%
N
31
Nuveen
North Carolina
$6.39M +$3.44M +634,141 +97%
TCM
32
Tang Capital Management
California
$6.32M -$1.22M -225,147 -15%
Fidelity Investments
33
Fidelity Investments
Massachusetts
$5.94M +$496K +91,494 +8%
Prudential Financial
34
Prudential Financial
New Jersey
$5.62M -$159K -29,316 -3%
PI
35
Putnam Investments
Massachusetts
$5.56M +$489K +90,220 +9%
PAM
36
Panagora Asset Management
Massachusetts
$5.31M -$52.4K -9,657 -0.9%
UBS Group
37
UBS Group
Switzerland
$4.69M +$4.34M +800,497 +551%
LOAMS
38
Lombard Odier Asset Management (Switzerland)
Switzerland
$4.65M – – –
Millennium Management
39
Millennium Management
New York
$4.63M -$4.92M -907,117 -49%
Fisher Asset Management
40
Fisher Asset Management
Washington
$4.23M +$1.45M +267,257 +46%
SAM
41
Sectoral Asset Management
Quebec, Canada
$3.99M -$243K -44,800 -5%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$3.91M -$145K -26,766 -3%
Barclays
43
Barclays
United Kingdom
$3.87M +$912K +168,152 +27%
TL
44
Tradewinds LLC
North Carolina
$3.71M +$91.3K +16,843 New
VOYA Investment Management
45
VOYA Investment Management
Georgia
$3.61M -$1.65M -304,318 -29%
Primecap Management
46
Primecap Management
California
$3.47M -$152K -28,100 -4%
Citigroup
47
Citigroup
New York
$2.99M -$1.64M -301,572 -33%
CM
48
CM Management
Florida
$2.48M – – –
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$2.41M -$1.05M -193,754 -29%
Swiss National Bank
50
Swiss National Bank
Switzerland
$2.38M +$48.3K +8,900 +2%
1
2
3 4 5

IMGN Hedge Fund Activity: Q4 2022 in Review

204 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2022, worth a combined $1B — up 5.8% from $948M a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IMGN and 27 opened new positions — a net loss of 17 holders — while 68 trimmed existing stakes and 69 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $27.3M. The largest seller was Deerfield Management, cutting an estimated $40M.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q4 2022, down from 222 in Q3 2022.
  • Funds reported $1B of Immunogen Inc stock for Q4 2022, up 5.8% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q4 2022 and 44 closed out, a net change of -17 holders.
  • The largest Immunogen Inc buyer in Q4 2022 was Woodline Partners, an estimated $27.3M added.
  • The largest Immunogen Inc seller in Q4 2022 was Deerfield Management, an estimated $40M sold.

Based on aggregated 13F filings for Q4 2022.